THE TRUTH ABOUT: Optimi health corp org | History Defined

Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research

VANCOUVER, British Columbia, June 16, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the "Company" or "Optimi"), a commercial-stage GMP pharmaceutical manufacturer of regulated psychedelic drug products, today announced it has completed production of two microdose psilocybin finished drug products, formulated at 1 mg and…

AAP · Jun 16

Optimi Closes Non-Brokered Private Placement, Here Are The Details

Canadian licensed producer of GMP-grade psilocybin Optimi Health Corp.

Benzinga · Oct 11, 2022

First International Psilocybin Supply Agreement For Optimi Health: Here Are The Details

Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian-based company licensed by Health Canada to produce and supply natural psilocybin and other psychedelic substances, announced that it has entered into its first international psi

Benzinga · Aug 30, 2022